Search

everythinglearnresearchcommunity

for

Search:↓

RC48 shows promise for treating certain advanced cancers, but more research is needed.

Ritlecitinib shows promise for treating alopecia areata, especially with early and extended treatment.

Erenumab significantly reduced migraine days or severity in most patients after 3 months.

Talazoparib is more effective than standard chemotherapy for advanced breast cancer with BRCA mutations.

Wedelolactone may help prevent bone damage in breast cancer by blocking certain cell signals.

CI-1033 causes skin lesions in rats, similar to humans, due to EGF receptor inhibition.

Eclipta alba extract may work as an anticancer agent and help reverse drug resistance.

EREG therapy may help treat hair loss by promoting hair growth.

Ritlecitinib effectively promotes hair regrowth in alopecia areata patients, even with extensive hair loss.

Using electronic health records can help identify drug side effects but has some limitations.

Leflunomide can cause severe hair loss in some rheumatoid arthritis patients.

Many pediatric epilepsy patients experience preventable severe adverse drug reactions, especially with certain medications and risk factors.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

Both LNG-IUD and systemic progestins are effective for fertility-sparing treatment, but close monitoring is needed due to recurrence risk.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Wedelolactone may help treat chronic diseases by acting as an antioxidant and affecting important proteins.

Ritlecitinib is generally safe for adolescents with alopecia areata over 5 years.

Eclipta alba has more wedelolactone, but Wedelia chinensis is better at fighting bacteria.

Erlotinib may cause scarring hair loss.

Doxycycline can effectively treat hair loss caused by EGFR inhibitors.

Doxycycline helps prevent skin issues from erlotinib in lung cancer patients.

Continued ritlecitinib treatment can improve hair regrowth in some alopecia areata patients who initially don't respond.

Henna ointment may help reduce itching and improve wound healing in patients with epidermolysis bullosa.

Eclipta alba extract reduces ulcers and protects the stomach in rats.

Levetiracetam is widely used and generally well-tolerated for treating idiopathic generalized epilepsies, with tiredness as the main side effect.

Levetiracetam may cause hair loss, which can potentially reverse with lower doses or stopping the drug.

Laser-Assisted Exosome Delivery showed early skin improvement without side effects, but more research is needed.

Leucaena feed helps farmers grow larger cattle herds and is good for fattening, but its safety for breeding cows is unclear.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.